Frontiers in Pharmacology | Pharmacoepidemiology

Original Research

Published on 10 Jan 2025

Overweight and glucose/lipid metabolism abnormality associated with SSRIs: a pharmacovigilance study based on the FDA adverse event reporting system

in Pharmacoepidemiology

Jinming Cao
Zhicong Chen
Yan Wang
Yunpeng Ma
Zhen Yang
Jian Cai
Zhijun Xiao
Feng Xu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1517546

2,804 views

Editorial

Published on 10 Jan 2025

Editorial: Biologic drugs in immune-mediated inflammatory diseases, validation, drug-utilization, effectiveness, regulation, costs, and safety in the real-world

in Pharmacoepidemiology

Irma Convertino
Luciane Cruz Lopes
Nicole Pratt
Ylenia Ingrasciotta
Marco Tuccori

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1542453

1,147 views
1 citation

Original Research

Published on 09 Jan 2025

Adverse drug events (ADEs) risk signal mining related to eculizumab based on the FARES database

in Pharmacoepidemiology

Xi-Feng Wang
Lu-Ri Bao
Ta-La Hu
Rui-Feng Xu
Wu-Niri Gao
Jing-Yuan Wang
Jian-Rong Zhao
Zhen-Li Fu
Shu-Fang Wang
Yan Meng

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1440907

3,815 views
1 citation

Original Research

Published on 08 Jan 2025

Safety of combined drug use in patients with cardiovascular and cerebrovascular diseases: an analysis based on the spontaneous reporting database of adverse drug reactions in Hubei Province

in Pharmacoepidemiology

Jia Wang
Yuhang Zhao
Zherui Chen
Rui Huang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1451713

1,525 views

Original Research

Published on 07 Jan 2025

Disproportionate adverse event signals of selumetinib in neurofibromatosis type I: insights from FAERS

in Pharmacoepidemiology

Lin Li

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1454418

2,119 views
1 citation

Original Research

Published on 07 Jan 2025

Comprehensive analysis of adverse events associated with onasemnogene abeparvovec (Zolgensma) in spinal muscular atrophy patients: insights from FAERS database

in Pharmacoepidemiology

Wenwen Zhang
Yizhen Yin
Dan Yang
Mengyuan Liu
Caixia Ye
Ruiling Yan
Ruiman Li

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1475884

3,781 views

Original Research

Published on 06 Jan 2025

Drug-induced urinary retention: a real-world pharmacovigilance study using FDA and Canada vigilance databases

in Pharmacoepidemiology

Xianyu Dai
Kai Yu
Yu Chang
Yuchuan Hou

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1466875

3,105 views
2 citations

Original Research

Published on 03 Jan 2025

Inappropriate prescribing of drugs for peptic ulcer and gastro-esophageal reflux disease remains a matter of concern: Results from the LAPTOP-PPI cluster randomized trial

in Pharmacoepidemiology

Manuela Casula
Ilaria Ardoino
Laura Pierini
Lara Perrella
Stefano Scotti
Sara Mucherino
Valentina Orlando
Enrica Menditto
Carlotta Franchi

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1430879

1,832 views

Original Research

Published on 23 Dec 2024

Safety assessment of deutetrabenazine: real-world adverse event analysis from the FAERS database

in Pharmacoepidemiology

Yanping Shu
Yuanhe Wang
Jiaoying Liu
Lingyan Hu
Sichao Tong
Gang Wu
Xianlin Zhu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1498215

2,056 views
1 citation

Original Research

Published on 18 Dec 2024

Drug-induced coagulopathies: a real-world pharmacovigilance study using the FDA adverse event reporting system

in Pharmacoepidemiology

Yanjun Lu
Qian Xu
Shita Zhu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1486422

2,212 views

Original Research

Published on 17 Dec 2024

Anti-migraine medications safety during pregnancy in the US

in Pharmacoepidemiology

A. Bérard
S. Strom
D. Albrecht
S. Kori

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1481378

1,264 views
1 citation

Original Research

Published on 17 Dec 2024

A real-world pharmacovigilance study of Sorafenib based on the FDA Adverse Event Reporting System

in Pharmacoepidemiology

Dongdong Zhang
Ying Cai
Yixin Sun
Peiji Zeng
Wei Wang
Wenhui Wang
Xiaohua Jiang
Yifan Lian

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1442765

2,070 views

Original Research

Published on 16 Dec 2024

Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry

in Pharmacoepidemiology

J. Riera-Arnau
E. Ballarín
R. Llop
E. Montané
P. Hereu
G. Vancells
N. Padullés-Zamora
A. M. Barriocanal
G. Cardona-Peitx
C. Casasnovas

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1420682

1,208 views

Original Research

Published on 16 Dec 2024

Cost-effectiveness analysis of combining lenalidomide with R-CHOP for treating diffuse large B-cell lymphoma in China

in Pharmacoepidemiology

Rongqi Li
Yuhan Zeng
Yizhang Chen
Zhongjiang Ye
Chuang Chen
Jianhui Yang
Jing Fu
Tao Zhou
Danna Jiang
Sunting Qin

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1412743

1,085 views

Original Research

Published on 13 Dec 2024

Drug-induced retinal vein occlusion: a disproportionality analysis from the FDA adverse event reporting system (2004–2023)

in Pharmacoepidemiology

Xiao-Dong Chen
Kun-Hong Xiao
Chao-Bing Zhou

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1480269

2,579 views
1 citation

Original Research

Published on 11 Dec 2024

A real-world pharmacovigilance study of neuroleptic malignant syndrome based on FDA adverse event reporting system

in Pharmacoepidemiology

Yu Zhang
Wei Deng
Minjian Wang
Siying Luo
Song Li

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1438661

1,682 views
2 citations